[Hormonotherapy for breast cancer prevention: What about women with genetic predisposition to breast cancer?]. 2016

Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Institut Bergonié, service de génétique - service de gynécologie, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address: c.senechal-davin@bordeaux.unicancer.fr.

In France, women carrying BRCA1/2 mutation, at an identified high risk of breast cancer are recommended to undergo breast MRI screening. That screening does not however prevent the risk of developing a breast cancer. The only alternative to breast cancer screening available in France is surgical prevention by prophylactic mastectomy. An interesting option for women who wish to reduce their breast cancer risk, but are unready for prophylactic mastectomy is a preventive hormonal treatment by aromatase inhibitors, or selective estrogens receptor modulators (SERMs). Reliable clinical trials show the efficiency of tamoxifen, raloxifen, exemestane, and anastrozole especially, in reducing breast cancer incidence by 33%, 34%, 65% and 53% respectively. This article tries to sum up the main published trials of breast cancer prevention with hormonal treatment, and presents the latest American and English clinical guidelines concerning hormonal prevention for women at high risk of breast cancer, and starts thinking about the possibilities of hormonoprevention, especially among women carrying a BRCA1/2 mutation in France.

UI MeSH Term Description Entries
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077384 Anastrozole A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile),Anastrazole,Arimidex,ICI D1033,ZD-1033,ZD1033,Zeneca ZD 1033,ZD 1033
D000730 Androstadienes Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
September 1992, Cancer,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
July 1998, The British journal of surgery,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
January 1996, Acta oncologica (Stockholm, Sweden),
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
February 1984, Cancer,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
February 1998, The British journal of surgery,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
January 1976, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
April 2023, Mayo Clinic proceedings,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
January 1996, The cancer journal from Scientific American,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
January 1997, The cancer journal from Scientific American,
Claire Sénéchal, and Fabien Reyal, and Nasrine Callet, and Pascale This, and Catherine Noguès, and Dominique Stoppa-Lyonnet, and Emmanuelle Fourme
October 1999, The Surgical clinics of North America,
Copied contents to your clipboard!